Skip to main content
. 2021 Aug 11;27:e930738-1–e930738-13. doi: 10.12659/MSM.930738

Table 4.

Adverse events of patients with squamous cell carcinoma of the lung treated with neoadjuvant nab-paclitaxel and carboplatin.

Event, n (%) ITT (n=36)
Any grade Grade 3 or 4
Neutropenia 17 (47.2) 6 (16.7)
Anemia 9 (25.0) 0
Leukopenia 9 (25.0) 0
Thrombocytopenia 3 (8.3) 0
Increased ALT 2 (5.6) 1 (2.8)
Increased bilirubin 1 (2.8) 1 (2.8)

ALT – alanine transaminase; ITT – intention-to-treat.